Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.

Link to article at PubMed

Icon for S. Karger AG, Basel, Switzerland Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central Related Articles

Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.

Nephron. 2020;144(5):213-221

Authors: Perico L, Benigni A, Remuzzi G

Abstract
Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.

PMID: 32203970 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published.